The Enterprise Value as of September 2024 (TTM) for Unity Biotechnology, Inc. (UBX) is 38.00M

According to Unity Biotechnology, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 38.00M. This represents a change of -9.87% compared to the average of 42.16M of the last 4 quarters.

Unity Biotechnology, Inc. (UBX) Historical Enterprise Value (quarterly & annually)

How has UBX Enterprise Value performed in the past?

The mean historical Enterprise Value of Unity Biotechnology, Inc. over the last ten years is 155.47M. The current 38.00M Enterprise Value has changed 2.34% with respect to the historical average. Over the past ten years (40 quarters), UBX's Enterprise Value was at its highest in in the December 2017 quarter at 690.40M. The Enterprise Value was at its lowest in in the June 2017 quarter at 0.

Unity Biotechnology, Inc. (UBX) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Unity Biotechnology, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Unity Biotechnology, Inc. (UBX) Average Enterprise Value

How has UBX Enterprise Value performed in the past?

The current Enterprise Value of Unity Biotechnology, Inc. (UBX) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Unity Biotechnology, Inc. (UBX) Enterprise Value vs. Peers

How is UBX’s Enterprise Value compared to its peers?

Unity Biotechnology, Inc.’s Enterprise Value is less than Exscientia plc (385.43M), less than Recursion Pharmaceuticals, Inc. (1.51B), less than Atea Pharmaceuticals, Inc. (95.47M), less than Icosavax, Inc. (713.87M), less than HOOKIPA Pharma Inc. (83.21M), less than Acumen Pharmaceuticals, Inc. (106.85M), less than Heron Therapeutics, Inc. (456.08M), greater than Homology Medicines, Inc. (-103303255.00), less than Avidity Biosciences, Inc. (4.66B), less than Beam Therapeutics Inc. (1.97B), less than Intellia Therapeutics, Inc. (2.26B), less than Editas Medicine, Inc. (294.27M), less than Verve Therapeutics, Inc. (397.27M), less than Prime Medicine, Inc. (463.71M), greater than Windtree Therapeutics, Inc. (4.03M), greater than Dermata Therapeutics, Inc. (-1986143.00), greater than Ensysce Biosciences, Inc. (3.14M), greater than Panbela Therapeutics, Inc. (5.93M), greater than Baudax Bio, Inc. (15.86M), greater than Neoleukin Therapeutics, Inc. (-6333315.00), less than Nuvation Bio Inc. (975.25M), less than Ovid Therapeutics Inc. (61.90M), greater than NextCure, Inc. (24.48M), greater than Connect Biopharma Holdings Limited (-40618512.00),

Build a custom stock screener for Unity Biotechnology, Inc. (UBX) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Unity Biotechnology, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Unity Biotechnology, Inc. (UBX) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Unity Biotechnology, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.